
NASDAQ:CLBT
3 expert ratings on Cellebrite (CLBT) in the last 12 months: 0 Buy, 3 Hold, 0 Sell. Latest rating: HOLD by Stockchase Insights on Nov 10, 2025.
We continue to like CLBT. The company reports Nov. 12 so in the least, we would prefer to wait for earnings and make a decision thereafter with more up to date info.
Unlock Premium - Try 5i Free
We continue to like CLBT. The company reports Nov. 12 so in the least, we would prefer to wait for earnings and make a decision thereafter with more up to date info.
Unlock Premium - Try 5i Free
Its performance has been disappointing, and we do look at momentum of stocks (negative here). But we still think it is worth holding for mid-cap growth investors. It has $500M cash, and good earnings growth is expected still, and the sector outlook overall remains robust.
Unlock Premium - Try 5i Free
It is very good at tracing data for the police, military and other agencies. One of the best use cases for AI is looking at data. This is so good for the overwhelming amount of info that police have to look at. CLBT scrubs the info to find clues and patterns and can find information quickly. It has $400 million in cash along with very good growth. With a market cap of less than $4 billion it is much smaller than other companies in the same field. The customer base gives confidence in the company. Buy 8 Hold 0 Sell 0
(Analysts’ price target is $22.43)Cellebrite is a American stock, trading under the symbol CLBT (previously CLBT-Q on Stockchase) on the NASDAQ (CLBT). It is usually referred to as NASDAQ:CLBT or CLBT
3 expert ratings on Cellebrite (CLBT) in the last 12 months: 0 Buy, 3 Hold, 0 Sell. Latest rating: HOLD by Stockchase Insights on Nov 10, 2025. Read the latest stock experts' ratings for Cellebrite.
Cellebrite was recommended as a Top Pick by Stockchase Insights on 2025-11-10. Read the latest stock experts ratings for Cellebrite.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Cellebrite.
Cellebrite is followed by 9 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-14, Cellebrite (CLBT) stock closed at a price of $11.67.
We continue to like CLBT. The company reports Nov. 12 so in the least, we would prefer to wait for earnings and make a decision thereafter with more up to date info.
Unlock Premium - Try 5i Free